Table 2

Characterization of βARs stably expressed in HEK 293 cells

Cell LineEC50 for EpinephrineReceptor DensityEpinephrineKdCoupling Efficiency ± S.E.M.
nM fmol/mg nM
HA-βAR-6HIS8.2  ± 1.24, n = 62119  ± 254, n = 6548  ± 133, n = 40.031  ± 0.009
PKA 15.3  ± 3.66, n = 61501  ± 154, n = 6503  ± 46, n = 30.021  ± 0.003
S355,356,364A15.5  ± 0.79, n = 42887  ± 353, n = 4579  ± 59, n = 30.012  ± 0.0012-150
S355,356A10.8  ± 2.23, n = 61680  ± 154, n = 6546  ± 160, n = 20.029  ± 0.017
S356,364A16.8  ± 2.32, n = 61663  ± 207, n = 6593  ± 62, n = 20.021  ± 0.003
S356A50.1  ± 12.31, n = 3691  ± 60, n = 3463  ± 139, n = 30.012  ± 0.004
S364A11.6  ± 0.73, n = 32281  ± 92, n = 3426  ± 55, n = 20.016  ± 0.002

Membranes were prepared from naı̈ve HEK 293 cells expressing the HA-βAR-6HIS or mutant βARs. The membranes were assayed as described under Materials and Methods for epinephrineK d, receptor density, and for epinephrine-stimulated adenylyl cyclase activity to determine the EC50 value. Eq. 1, given under Materials and Methods, was used to calculate the coupling efficiency. The mean ± S.E.M. is given. None of the coupling efficiency values were significantly different, except for S355,356,364A.

    • 2-150  Significantly different from PKA,P < .05.